New four-component ugi-type reaction. Synthesis of heterocyclic structures containing a pyrrolo[1,2-a][1,4]diazepine fragment

Journal of Organic Chemistry

Volumn 70, Issue 4, 2005, Pages 1478-1481

  Ilyn, Alexey P ^a   Trifilenkov, Andrey S ^b   Kuzovkova, Julia A ^b   Kutepov, Sergey A ^b   Nikitin, Alexandre V ^b   Ivachtchenko, Alexandre V ^a  

^a CHEMDIV INC   (United States)

^b Chemical Diversity Research Institute   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC COMPOUNDS; CHEMICAL MODIFICATION; COMPLEXATION; CONDENSATION; SUBSTITUTION REACTIONS; SYNTHESIS (CHEMICAL);

FOUR-COMPONENT UGI CONDENSATION; HETEROCYCLIC STRUCTURES; PYRROLO[1,2-Α][1,4]DIAZEPINE;

REACTION KINETICS;

DIAZEPINE DERIVATIVE; HETEROCYCLIC COMPOUND; PYRROLE DERIVATIVE; PYRROLO[1,2 A][1,4]DIAZEPINE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; CHEMISTRY; POLYMERIZATION; SYNTHESIS; UGI REACTION;

ANTINEOPLASTIC AGENTS; BENZODIAZEPINES; MOLECULAR STRUCTURE;

EID: 13844322286     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo048204b     Document Type: Article

References (23)

1. (a) Kaneko, T.; Wong, H.; Doyle, T. W.; Rose, W. C.; Bradner, W. T. J. Med. Chem. 1985, 28, 388-392.
2. (b) Lisowski, V.; Fabis, F.; Pierre, A.; Caignard, D. H.; Renard, P.; Rault, S. J. Enzyme Inhib. Med. Chem. 2002, 17, 403-407.
3. (a) Hara, T.; Kayama, Y.; Mori, T.; Itoh, K.; Fujimori, H.; Sunami, T.; Hashimoto, Y.; Ishimoto, S. J. Med. Chem. 1978, 21, 263-268.
4. (b) Vega, S.; Gil, M. S.; Darias, V.; Sanchez Mateo, C. C.; Exposito, M. A.; Tello, M. L.; Albertos, L. M. Arch. Pharm. (Weinheim, Ger.) 1994, 327, 721-728.
5. (c) Vega, S.; Gil, M. S.; Darias, V.; Sanchez Mateo, C. C.; Exposito, M. A. Pharmazie 1995, 50, 27-33.
6. (d) Massa, S.; Corelli, F.; Artico, M.; Mai, A.; Silvestri, R.; Pantaleoni, G. C.; Palumbo, G.; Fanini, D.; Giorgi, R. Farmacol. 1989, 44, 109-123.
7. (e) Massa, S.; Artico, M.; Mai, A.; Corelli, F.; Pantaleoni, G. C.; Giorgi, R.; Ottaviani, D.; Cagnotto, A. Farmacologia 1990, 45, 1265-1281.
8. (a) Atack, J. R. Curr. Drug Targets CNS Neurol. Disord. 2003, 2, 213-232.
9. (b) Martin, J. R.; Jenck, F.; Moreau, J. L. J. Pharmacol. Exp. Ther. 1995, 275, 405-411.
10. Codding, P. W.; Muir, A. K. Mol. Pharmacol. 1985, 28, 178-184.
11. Raines, S.; Chai, S. Y.; Palopoli, F. P. J. Heterocycl. Chem. 1976, 13, 711-716.
12. Boulouard, M.; Dallemagne, P.; Alsaiedi, A.; Rault, S. J. Heterocycl. Chem. 1996, 33, 1743-1749.
13. Boulouard, M.; Rault, S.; Alsaidi, A.; Dallemagne, P.; Robba, M. J. Heterocycl. Chem. 1995, 32, 1719-1724.
14. Feng, X.; Lancelot, J.-C.; Gillard, A.-C.; Landelle, H.; Rault, S. J. Heterocycl. Chem. 1998, 35, 1313-1316.
15. (a) Ugi, I.; Lohberger, S.; Karl, R. The Passerini and Ugi Reactions. In Comprehensive Organic Synthesis; Trost, B. M., Flemming, I., Heathcock, C. Eds.; Pergamon Press: Oxford, 1991; Vol. 2, pp 1083-1109.
16. (b) Domling, A.; Ugi, I. Angew. Chem., Int. Ed. 2000, 39, 3168-3210.
17. Short, K. M.; Mjalli, A. M. M. Tetrahedron Lett. 1897, 38, 359-362.
18. Zhang, J.; Jacobson, A.; Rusche, J. R.; Herlihy, W. J. Org. Chem. 1999, 64, 1074-1076.
19. Ley, S. V.; Taylor, S. J. Bioorg. Med. Chem. Lett. 2002, 12, 1813-1816.
20. (a) Marcaccini, S.; Pepino, R.; Torroba, T.; Miguel, D.; Garcia-Valverde, M. Tetrahedron Lett. 2002, 43, 8591-8593.
21. (b) Marcaccini, S.; Miguel, D.; Torroba, T.; Garcia-Valverde, M. J. Org. Chem. 2003, 68, 3315-3318.
22. (a) Kennedy, A. L.; Fryer, A. M.; Josey, J. A. Org. Lett. 2002, 4, 1167-1170.
23. (b) Keating, T. A.; Armstrong, R. W. J. Org. Chem. 1996, 61, 8935-8939.